Paper21990358
Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells.
Schmidt J and 5 others. J Biol Chem, 2011. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells. Papers, record 21990358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21990358
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD8-Positive T-Lymphocytes | Major topic |
| HLA-A2 Antigen | Major topic |
| Histidine | Major topic |
| Nickel | Major topic |
| Nitrilotriacetic Acid | Major topic |
| Peptides | Major topic |
| Humans | |
| MART-1 Antigen | |
| Staining and Labeling |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19777993 | Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. | Cancer Immun | 2009 | https://conductscience.org/library/papers/19777993 | PubMed |
| 2 | 11371361 | A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. | Immunity | 2001 | https://conductscience.org/library/papers/11371361 | PubMed |
| 3 | 15905522 | Soluble MHC-peptide complexes induce rapid death of CD8+ CTL. | J Immunol | 2005 | https://conductscience.org/library/papers/15905522 | PubMed |
| 4 | 16642995 | Double-hexahistidine tag with high-affinity binding for protein immobilization, purification, and detection on ni-nitrilotriacetic acid surfaces. | Anal Chem | 2006 | https://conductscience.org/library/papers/16642995 | PubMed |
| 5 | 16826567 | Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments. | Proteomics | 2006 | https://conductscience.org/library/papers/16826567 | PubMed |
| 6 | 17306825 | Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens. | J Immunol Methods | 2007 | https://conductscience.org/library/papers/17306825 | PubMed |
| 7 | 12374858 | Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12374858 | PubMed |
| 8 | 19876964 | Insight into the complexation mode of bis(nitrilotriacetic acid) (NTA) ligands with Ni(2+) involved in the labeling of histidine-tagged proteins. | Chemistry | 2009 | https://conductscience.org/library/papers/19876964 | PubMed |
| 9 | 10796983 | Streptavidin-biotin binding energetics. | Biomol Eng | 1999 | https://conductscience.org/library/papers/10796983 | PubMed |
| 10 | 9344407 | BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip. | Anal Biochem | 1997 | https://conductscience.org/library/papers/9344407 | PubMed |
| 11 | 19330843 | Quantitative evaluation of His-tag purification and immunoprecipitation of tristetraprolin and its mutant proteins from transfected human cells. | Biotechnol Prog | 2009 | https://conductscience.org/library/papers/19330843 | PubMed |
| 12 | 19998338 | Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma. | Int J Cancer | 2010 | https://conductscience.org/library/papers/19998338 | PubMed |
| 13 | 12555674 | Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes. | Eur J Immunol | 2002 | https://conductscience.org/library/papers/12555674 | PubMed |
| 14 | 16951353 | Fluorescence-activated cell sorting and cloning of bona fide CD8+ CTL with reversible MHC-peptide and antibody Fab' conjugates. | J Immunol | 2006 | https://conductscience.org/library/papers/16951353 | PubMed |
| 15 | 21256056 | Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination. | Immunity | 2011 | https://conductscience.org/library/papers/21256056 | PubMed |
| 16 | 7830771 | CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. | Nature | 1995 | https://conductscience.org/library/papers/7830771 | PubMed |
| 17 | 19650657 | Tris-nitrilotriacetic acids of subnanomolar affinity toward hexahistidine tagged molecules. | Bioconjug Chem | 2009 | https://conductscience.org/library/papers/19650657 | PubMed |
| 18 | 20164930 | TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. | Nature | 2010 | https://conductscience.org/library/papers/20164930 | PubMed |
| 19 | 19235144 | Oligohis-tags: mechanisms of binding to Ni2+-NTA surfaces. | J Mol Recognit | 2009 | https://conductscience.org/library/papers/19235144 | PubMed |
| 20 | 19125886 | Tricks with tetramers: how to get the most from multimeric peptide-MHC. | Immunology | 2009 | https://conductscience.org/library/papers/19125886 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42548059 | Peptide exchange-competent class I MHC molecules produced in eukaryotic cells for rapid production of MHC multimers. | J Immunol | 2026 | https://conductscience.org/library/papers/42548059 | PubMed |
| 41709576 | Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homing. | Mol Ther | 2026 | https://conductscience.org/library/papers/41709576 | PubMed |
| 38053994 | Overall avidity declines in TCR repertoires during latent CMV but not EBV infection. | Front Immunol | 2023 | https://conductscience.org/library/papers/38053994 | PubMed |
| 37280206 | Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors. | Nat Commun | 2023 | https://conductscience.org/library/papers/37280206 | PubMed |
| 35228747 | Bystander T cells in cancer immunology and therapy. | Nat Cancer | 2022 | https://conductscience.org/library/papers/35228747 | PubMed |
| 34739845 | Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation. | Cancer Cell | 2021 | https://conductscience.org/library/papers/34739845 | PubMed |
| 33972472 | MHC multimer: A Molecular Toolbox for Immunologists. | Mol Cells | 2021 | https://conductscience.org/library/papers/33972472 | PubMed |
| 33796916 | Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen. | Cancer Immunol Immunother | 2021 | https://conductscience.org/library/papers/33796916 | PubMed |
| 33665637 | Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting. | Cell Rep Med | 2021 | https://conductscience.org/library/papers/33665637 | PubMed |
| 33539685 | Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents. | Curr Protoc | 2021 | https://conductscience.org/library/papers/33539685 | PubMed |
| 32695101 | Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal. | Front Immunol | 2020 | https://conductscience.org/library/papers/32695101 | PubMed |
| 31969886 | High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence. | Front Immunol | 2019 | https://conductscience.org/library/papers/31969886 | PubMed |
| 29545564 | Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer. | Nat Commun | 2018 | https://conductscience.org/library/papers/29545564 | PubMed |
| 28975614 | T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus. | Eur J Immunol | 2018 | https://conductscience.org/library/papers/28975614 | PubMed |
| 28724801 | TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency. | JCI Insight | 2017 | https://conductscience.org/library/papers/28724801 | PubMed |
| 28604446 | Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. | Transplantation | 2017 | https://conductscience.org/library/papers/28604446 | PubMed |
| 26635796 | Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens. | Front Immunol | 2015 | https://conductscience.org/library/papers/26635796 | PubMed |
| 23908656 | Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes. | Front Immunol | 2013 | https://conductscience.org/library/papers/23908656 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACSM3 | 6296 | PubTator's text mining | https://conductscience.org/library/genes/6296 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| MLANA | 2315 | PubTator's text mining | https://conductscience.org/library/genes/2315 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21990358
GET https://conductscience.org/api/papers/v1/21990358/references?page=2